Multicentre, prospective, randomised controlled trial to evaluate hexaminolevulinate photodynamic therapy (Cevira) as a novel treatment in patients with high-grade squamous intraepithelial lesion: APRICITY phase 3 study protocol
- Resource Type
- article
- Source
- BMJ Open, Vol 12, Iss 6 (2022)
- Subject
Medicine - Language
- English
- ISSN
- 2044-6055